Landscape Capital Management’s Jasper Therapeutics JSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$137K Buy
+7,888
New +$159K 0.01% 558
2024
Q2
– Sell
-380
Closed -$335K – 804
2024
Q1
$335K Sell
380
-2,251
-86% -$1.2M 0.03% 519
2023
Q4
$623K Buy
+2,631
New +$530K 0.06% 344
2021
Q3
– Sell
-283
Closed -$844K – 787
2021
Q2
$844K Buy
+283
New +$844K 0.1% 210

Other funds holding JSPR

Landscape Capital Management's JSPR Position: Q3 2026 in Review

Landscape Capital Management opened a new position in Jasper Therapeutics (JSPR) in Q3 2026: 7,888 shares worth $137K. The stake represents 0.01% of the portfolio and ranks #558 among its holdings. This is a return to the name: Landscape Capital Management previously reported a position in JSPR as recently as Q1 2024.

Landscape Capital Management first reported a position in JSPR in Q2 2021 and has held it in 4 quarters since. The position peaked at $844K in Q2 2021. 27 funds tracked by Wall St. Rank hold JSPR as of Q3 2026.

  • Landscape Capital Management held 7,888 shares of Jasper Therapeutics worth $137K as of Q3 2026.
  • Jasper Therapeutics was a new Landscape Capital Management position in Q3 2026.
  • Jasper Therapeutics made up 0.01% of Landscape Capital Management's portfolio in Q3 2026, its #558 holding.
  • Landscape Capital Management first reported a position in Jasper Therapeutics in Q2 2021 and has held it in 4 quarters since.
  • Landscape Capital Management's Jasper Therapeutics position peaked at $844K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2026.

Based on Landscape Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.